Early research (Phase 1)Study completedNCT03886831
What this trial is testing
PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
Who this might be right for
Relapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more
Prelude Therapeutics Incorporated 232